LOS ANGELES, CALIFORNIA - AUGUST 15, 2022 - The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP), centered at Children's Hospital Los Angeles, awarded $210,000 in seed grants on August 15, 2022, to accelerate projects specifically designed to improve the safety and delivery of care to infants and children.
Five innovators developing novel devices and technologies for pediatric patients were selected as winners for CTIP’s sixth annual Catalyzing Pediatric Innovation (CPI) Grant competition.
Children have long been an underserved population in the technology space, with many having to deal with ill-fitted medical devices and a lack of access to effective diagnostic or therapeutic devices. Pediatric medical device innovators face financial, regulatory, and scientific barriers to get their solutions in the hands of patients and providers. The CPI Grant is one way CTIP helps founders target these obstacles, alongside our platform of services to help guide the advancement of pediatric medical devices.
CPI Grant applicants proposed many innovative devices designed to address serious complications in children, covering all pediatric age ranges and care settings. Applications included device projects across 22 different pediatric subspecialties (most common: neonatology and cardiovascular), all anticipated FDA device classes (Class I, II, and III), and were received from 24 states, including 35% of applications from California.
The 2022 winners are as follows:
The Eclipse XL1 Distraction Enterogenesis System utilizes a mechanical device to stimulate the body to grow new intestines as a treatment for short bowel syndrome.
Equalize Health is launching a neonatal CPAP, FlowLite, with features designed to solve the key barriers to delivering effective therapy for newborn respiratory distress in low-resource settings.
The Orchid SRV™ connects via standard luer-locking connection, allowing flow during IV therapy. The Orchid SRV™ is designed to allow the device to separate into two halves when excessive tension acts on the Orchid SRV™, automatically closing the flow path to both IV extension set and IV administration set. Following separation, a component of the Orchid SRV™ is left attached to each side of the infusion system to protect the intraluminal pathway. Upon separation, replacement of the SRV™ is necessary. Follow institutional policy to replace the SRV™, or at least every seven (7) days.
The enLumin is a portable, intuitive, and connected enteral feeding system designed to transform the lives of those who require supplemental nutrition.
"Joint thermometer", a software decoding infrared thermal images from patients with arthritis provides hope for accurate and convenient monitoring of joint health with increasing usage of telehealth.